Ipsen’s partner Roche announces that Taspoglutide meets its primary endpoints in head-to-head study with sitagliptin (Januvia®) and versus placebo (Press release issued by Ipsen)
FDA Rejects Merck KGaA’s NDA for MS Treatment (FDA News)
Building A Better Patient Registry: Keep It Simple, But Let It Be Big (The Pink Sheet)
This is copyright protected information, to receive the full article, please click here to sign up and register.
Funding crisis “may force Euro biopharma out of R&D” (PharmaTimes)
Pfizer links up with Protalix, outlines generics plan for Japan (PharmaTimes)
RSNA: Appendicitis? There’s an App for That (MedPage Today)
WHO Approves Glaxo’s Swine Flu Shot (Therapeutics Daily)
Healthcare Roundtable 2009: Changes in protocol (PR Week)
Stryker’s Buy Of Ascent Provides Returns >SYK (Wall Street Journal)
FDA Fast-Track Approves Novartis Seasonal Flu Vaccine (AHN)
UPDATE 1-Roche-licensed diabetes drug meets trial targets (Reuters)
Gilead set to benefit from HIV guidelines (Financial Times)
Lilly introduces website to help depression patients to recover (PharmaBiz)
SUBSCRIBE